🇺🇸 PROPANTHELINE BROMIDE in United States

FDA authorised PROPANTHELINE BROMIDE on 15 January 1975

Marketing authorisations

FDA — authorised 15 January 1975

  • Application: ANDA083029
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: PROPANTHELINE BROMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 4 August 1976

  • Application: ANDA080977
  • Marketing authorisation holder: PVT FORM
  • Local brand name: PROPANTHELINE BROMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 18 May 1983

  • Application: ANDA087663
  • Marketing authorisation holder: ASCOT
  • Local brand name: PROPANTHELINE BROMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 16 June 1988

  • Application: ANDA088377
  • Marketing authorisation holder: PAR PHARM
  • Local brand name: PROPANTHELINE BROMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA085780
  • Marketing authorisation holder: HEATHER
  • Local brand name: PROPANTHELINE BROMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA083151
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: PROPANTHELINE BROMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

FDA

  • Application: ANDA084541
  • Marketing authorisation holder: IMPAX LABS
  • Local brand name: PROPANTHELINE BROMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA083706
  • Marketing authorisation holder: MYLAN
  • Local brand name: PROPANTHELINE BROMIDE
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

PROPANTHELINE BROMIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PROPANTHELINE BROMIDE approved in United States?

Yes. FDA authorised it on 15 January 1975; FDA authorised it on 4 August 1976; FDA authorised it on 18 May 1983.

Who is the marketing authorisation holder for PROPANTHELINE BROMIDE in United States?

WATSON LABS holds the US marketing authorisation.